Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs MACOM Technology (MTSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs MACOM Technology — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.34 (market cap $12.58B), while MACOM Technology trades at $330.18 (market cap $24.61B). The key difference: MACOM Technology is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, MACOM Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and MACOM Technology for 6 Days on average.
| HALO | MTSI | |
|---|---|---|
Market Cap | $12.58B | $24.61B |
Volume | 2,179,278 | 1,594,575 |
Sector | Health | Technology |
52-Week High | $115.22 | $409.68 |
52-Week Low | $61.63 | $122.18 |
Typical Hold Time | 1 Days | 6 Days |
Enterprise Value | $14.49B | $24.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About MACOM Technology
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →
